Use of human hepatocytes to investigate blood coagulation factor.

Methods Mol Biol

CHU Montpellier, Service d'Hématologie, Hôpital Saint Eloi, Montpellier, France.

Published: October 2010

Coagulation is the complex process by which activation of plasmatic haemostasis proteins ends up with the generation of fibrin. Most of the plasma coagulation proteins are synthesized in hepatocytes. The aim of this chapter is to describe experimental procedures allowing to measure the secretion by primary human hepatocytes and functional activity (including production of fibrillar material from extracellular medium) of haemostasis proteins including factors II, V, VII, VIII, PIVKA-II (protein induced by vitK 1 absence or antagonist II), antithrombin and protein S. In addition, we show how treatments of hepatocyte cultures with vitamin K and/or warfarin affect the secretion of haemostasis proteins. The results demonstrate that primary cultures of human hepatocytes constitute an invaluable model for investigating haemostasis protein expression and activity and therapeutic strategies targeting these proteins.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-60761-688-7_23DOI Listing

Publication Analysis

Top Keywords

human hepatocytes
12
haemostasis proteins
12
proteins
5
hepatocytes investigate
4
investigate blood
4
blood coagulation
4
coagulation factor
4
factor coagulation
4
coagulation complex
4
complex process
4

Similar Publications

Inclisiran, Reasons for a Novel Agent in a Crowded Therapeutic Field.

Curr Atheroscler Rep

January 2025

Unitat de Medicina Vascular I Metabolismo, Hospital Universitario Sant Joan, Universitat Rovira I Virgili, IISPV, CIBERDEM, Reus, Spain.

Purpose Of The Review: A significant number of patients fail to achieve target LDL cholesterol (LDL-C) levels. This review aims to explore why inclisiran, a novel class of LLT, should be considered a valuable addition to the current treatment options.

Recent Findings: Inclisiran is a small interfering RNA (siRNA) that targets PCSK9 synthesis specifically in the hepatocytes.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany, Cologne, North-rhine westphalia, Germany.

Background: Alzheimer's disease (AD) presents a prolonged asymptomatic phase, providing a significant timeframe for potential intervention. Leveraging this opportunity necessitates the early identification of diagnostic and prognostic biomarkers to detect Alzheimer's pathology during predementia stages. This enables the identification of individuals likely to progress to Alzheimer's-type dementia, allowing them to benefit from targeted disease-modifying therapies.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

UAB, Birmingham, AL, USA.

Background: Individual plasma protein biomarkers have been shown to correlate with cognitive performance in people with HIV. This study aimed to investigate the association between plasma proteomic signatures and cognition in virologically well-controlled women with HIV.

Method: 77 women with HIV from three Women's Interagency Study (WIHS) sites completed neuropsychological testing and a blood draw.

View Article and Find Full Text PDF

Macrophage Membrane-Cloaked ROS-Responsive Albumin Nanoplatforms for Targeted Delivery of Curcumin to Alleviate Acute Liver Injury.

Mol Pharm

January 2025

Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China.

Developing low-toxicity, high-efficacy, and fast-acting strategies to manage acute liver injury (ALI) is critical due to its rapid progression and potential for severe outcomes. Curcumin (CUR) has shown promise in ALI therapy due to its ability to modulate the inflammatory microenvironment by scavenging reactive oxygen species (ROS). Nevertheless, CUR is highly hydrophobic limiting its bioavailability and effective in vivo transport, which hinders its further application.

View Article and Find Full Text PDF

Developing Topics.

Alzheimers Dement

December 2024

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Background: Cardiometabolic disorders represent a pressing public health challenge and confer heightened susceptibility to age-related cognitive decline, including increased risk of developing Alzheimer's disease (AD). There is a strong genetic component underlying risks for these conditions, and human Genome-Wide Association Studies (GWAS) have associated the PPP1R3B genetic locus with both cardiometabolic dysfunction and AD. PPP1R3B protein is primarily expressed in liver hepatocytes, regulating liver glycogen metabolism.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!